Abstract
Thyroid gland has been implicated in the regulation of many functions using endocrine, paracrine and autocrine signals. Functional thyroid follicular cells derived from stem cells attracted a great interest from researchers as a strategy for thyroid’s regenerative therapy. Thyroid has a very low rate of turnover; however, studies showed that the regenerative ability is enhanced following diseases or thyroidectomy, which promotes the role of stem cell. The objective of this review is to summarize the morphological characterization and the expression of stem cell genes/markers in the thyroid. Also, to highlight the mechanisms of tumor formation in thyroid via its stem cells. The most important thyroid stem cell’s markers are: stem cell antigen 1 (SCA-1), octamer-binding transcription 4 (OCT-4), p63, CD34+ CD45-, paired box gene 8 (PAX-8), thyroid transcription factor 1 (TTF-1), thyroid transcription factor 2 (TTF-2), hematopoietically expressed homeobox protein HHEX, the transcription factor GATA-4, hepatocyte nuclear factor 4-α (HNF-4-α) and homeobox transcription factor Nanog (hNanog). This review highlights the functional characterization describing the mechanisms of stem cell’s differentiation into functional thyroid follicle and proposing mechanisms involving in cancer formation through one of these cell types: fetal cell, thyroblasts, prothyrocytes, certain genetic mutation in the mature thyroid cells or presence of a special type of cells (cancer stem cell) which are responsible for different types of cancer formation. Understanding the mechanisms of thyroid’s stem cell in cancer formation and the expression of the biomarkers in normal and abnormal thyroid status are promising physiological tools in promoting thyroid regeneration and in provision management for thyroid cancer.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11154-019-09496-x/MediaObjects/11154_2019_9496_Fig1_HTML.png)
Similar content being viewed by others
References
Ozaki T, Matsubara T, Seo D, Okamoto M, Nagashima K, Sasaki Y, et al. Thyroid regeneration: characterization of clear cells after partial thyroidectomy. Endocrinology. 2012;153(5):2514–25.
Sadler, T. W. and Langman, J. M. E. (2010) Langman's medical embryology. 11th ed., international ed. / T.W. Sadler ; original illustrations by Jill Leland ; computer illustrations by Susan L. Sadler-Redmond ; scanning electron micrographs by Kathy Tosney ; ultrasound images by Nancy Cheschier and Hytham Imseis. edn. Philadelphia: Wouters Kluwer/Lippincott Williams & Wilkins.
Johansson E, Andersson L, Örnros J, Carlsson T, Ingeson-Carlsson C, Liang S, et al. Revising the embryonic origin of thyroid C cells in mice and humans. Development. 2015;142(20):3519–28.
Nilsson M, Williams D. On the origin of cells and derivation of thyroid Cancer: C cell story revisited. Eur Thyroid J. 2016;5(2):79–93.
Salvatore D. Deiodinases and stem cells: an intimate relationship. J Endocrinol Investig. 2018;41(1):59–66.
Khanlarkhani N, Baazm M, Mohammadzadeh F, Najafi A, Mehdinejadiani S, Sobhani A. Multipotent stem cell and reproduction. J Stem Cells. 2016;11(4):219–29.
Thomas D, Friedman S, Lin RY. Thyroid stem cells: lessons from normal development and thyroid cancer. Endocr Relat Cancer. 2008;15(1):51–8.
Dumont JE, Lamy F, Roger P, Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev. 1992;72(3):667–97.
Johansen R, Gardner RE, Galante M, Marchi FF, Ledwich TW, SOLEY MH, et al. An experimental study of thyroid regeneration following subtotal thyroidectomy. Surg Gynecol Obstet. 1951;93(3):303–9.
Hoshi N, Kusakabe T, Taylor BJ, Kimura S. Side population cells in the mouse thyroid exhibit stem/progenitor cell-like characteristics. Endocrinology. 2007;148(9):4251–8.
Chen CY, Kimura H, Landek-Salgado MA, Hagedorn J, Kimura M, Suzuki K, et al. Regenerative potentials of the murine thyroid in experimental autoimmune thyroiditis: role of CD24. Endocrinology. 2009;150(1):492–9.
Lehner B, Sandner B, Marschallinger J, Lehner C, Furtner T, Couillard-Despres S, et al. The dark side of BrdU in neural stem cell biology: detrimental effects on cell cycle, differentiation and survival. Cell Tissue Res. 2011;345(3):313–28.
Okamoto M, Hayase S, Miyakoshi M, Murata T, Kimura S. 'Stem cell antigen 1-positive mesenchymal cells are the origin of follicular cells during thyroid regeneration. PLoS One. 2013;8(11):e80801.
Kimura S. Thyroid regeneration: how stem cells play a role? Front Endocrinol (Lausanne). 2014;5:55.
Reis-Filho JS, Preto A, Soares P, Ricardo S, Cameselle-Teijeiro J, Sobrinho-Simões M. p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin. Mod Pathol. 2003;16(1):43–8.
Thomas T, Nowka K, Lan L, Derwahl M. Expression of endoderm stem cell markers: evidence for the presence of adult stem cells in human thyroid glands. Thyroid. 2006;16(6):537–44.
Lan L, Cui D, Nowka K, Derwahl M. Stem cells derived from goiters in adults form spheres in response to intense growth stimulation and require thyrotropin for differentiation into thyrocytes. J Clin Endocrinol Metab. 2007;92(9):3681–8.
Fierabracci A, Puglisi MA, Giuliani L, Mattarocci S, Gallinella-Muzi M. Identification of an adult stem/progenitor cell-like population in the human thyroid. J Endocrinol. 2008;198(3):471–87.
Satterthwaite AB, Burn TC, Le Beau MM, Tenen DG. Structure of the gene encoding CD34, a human hematopoietic stem cell antigen. Genomics. 1992;12(4):788–94.
Korostylev A, Mahaddalkar PU, Keminer O, Hadian K, Schorpp K, Gribbon P, et al. A high-content small molecule screen identifies novel inducers of definitive endoderm. Mol Metab. 2017;6(7):640–50.
Lin RY, Kubo A, Keller GM, Davies TF. Committing embryonic stem cells to differentiate into thyrocyte-like cells in vitro. Endocrinology. 2003;144(6):2644–9.
Arufe MC, Lu M, Kubo A, Keller G, Davies TF, Lin RY. Directed differentiation of mouse embryonic stem cells into thyroid follicular cells. Endocrinology. 2006;147(6):3007–15.
Arufe MC, Lu M, Lin RY. Differentiation of murine embryonic stem cells to thyrocytes requires insulin and insulin-like growth factor-1. Biochem Biophys Res Commun. 2009;381(2):264–70.
Ma R, Latif R, Davies TF. Thyrotropin-independent induction of thyroid endoderm from embryonic stem cells by activin a. Endocrinology. 2009;150(4):1970–5.
Jiang N, Hu Y, Liu X, Wu Y, Zhang H, Chen G, et al. Differentiation of E14 mouse embryonic stem cells into thyrocytes in vitro. Thyroid. 2010;20(1):77–84.
Ma R, Latif R, Davies TF. Thyroid follicle formation and thyroglobulin expression in multipotent endodermal stem cells. Thyroid. 2013;23(4):385–91.
Arauchi A, Matsuura K, Shimizu T, Okano T. Functional thyroid follicular cells differentiation from human-induced pluripotent stem cells in suspension culture. Front Endocrinol (Lausanne). 2017;8:103.
Antonica F, Kasprzyk DF, Opitz R, Iacovino M, Liao XH, Dumitrescu AM, et al. Generation of functional thyroid from embryonic stem cells. Nature. 2012;491(7422):66–71.
Davies TF, Latif R, Minsky NC, Ma R. Clinical review: the emerging cell biology of thyroid stem cells. J Clin Endocrinol Metab. 2011;96(9):2692–702.
Onyshchenko MI, Panyutin IG, Panyutin IV, Neumann RD. Stimulation of cultured h9 human embryonic stem cells with thyroid stimulating hormone does not lead to formation of thyroid-like cells. Stem Cells Int. 2012;2012:634914.
Hick AC, Delmarcelle AS, Bouquet M, Klotz S, Copetti T, Forez C, et al. Reciprocal epithelial:endothelial paracrine interactions during thyroid development govern follicular organization and C-cells differentiation. Dev Biol. 2013;381(1):227–40.
Murata T, Iwadate M, Takizawa Y, Miyakoshi M, Hayase S, Yang W, et al. An adult mouse thyroid side population cell line that exhibits enriched epithelial-mesenchymal transition. Thyroid. 2017;27(3):460–74.
Hussain F, Iqbal S, Mehmood A, Bazarbashi S, ElHassan T, Chaudhri N. Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000-2010. Hematol Oncol Stem Cell Ther. 2013;6(2):58–64.
Alghamdi IG, Hussain II, Alghamdi MS, Dohal AA, Almalki SS, El-Sheemy MA. The incidence rate of thyroid cancer among women in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer registry 2001-2008. J Immigr Minor Health. 2015;17(3):638–43.
Zane M, Scavo E, Catalano V, Bonanno M, Todaro M, De Maria R, et al. Normal vs cancer thyroid stem cells: the road to transformation. Oncogene. 2016;35(7):805–15.
Gao YJ, Li B, Wu XY, Cui J, Han JK. Thyroid tumor-initiating cells: increasing evidence and opportunities for anticancer therapy (review). Oncol Rep. 2014;31(3):1035–42.
Cicatiello AG, Ambrosio R, Dentice M. Thyroid hormone promotes differentiation of colon cancer stem cells. Mol Cell Endocrinol. 2017;459:84–9.
Zhang P, Zuo H, Ozaki T, Nakagomi N, Kakudo K. Cancer stem cell hypothesis in thyroid cancer. Pathol Int. 2006;56(9):485–9.
Burstein DE, Nagi C, Wang BY, Unger P. 'Immunohistochemical detection of p53 homolog p63 in solid cell nests, papillary thyroid carcinoma, and hashimoto's thyroiditis: a stem cell hypothesis of papillary carcinoma oncogenesis. Hum Pathol. 2004;35(4):465–73.
Takano T, Amino N. Fetal cell carcinogenesis: a new hypothesis for better understanding of thyroid carcinoma. Thyroid. 2005;15(5):432–8.
Takano T. Fetal cell carcinogenesis of the thyroid: theory and practice. Semin Cancer Biol. 2007;17(3):233–40.
Lin RY. Thyroid cancer stem cells. Nat Rev Endocrinol. 2011;7(10):609–16.
Benedict M, Costa J. Metastatic papillary thyroid carcinoma with multifocal synchronous transformation to anaplastic thyroid carcinoma. Case Rep Pathol. 2016;2016:4863405.
Papp S, Asa SL. When thyroid carcinoma goes bad: a morphological and molecular analysis. Head Neck Pathol. 2015;9(1):16–23.
Mitsutake N, Iwao A, Nagai K, Namba H, Ohtsuru A, Saenko V, et al. Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology. 2007;148(4):1797–803.
Nagayama Y, Shimamura M, Mitsutake N. Cancer stem cells in the thyroid. Front Endocrinol (Lausanne). 2016;7:20.
Mahkamova K, Latar N, Aspinall S, Meeson A. Hypoxia increases thyroid Cancer stem cell-enriched side population. World J Surg. 2018;42(2):350–7.
Yeung BH, Law AY, Wong CK. Evolution and roles of stanniocalcin. Mol Cell Endocrinol. 2012;349(2):272–80.
Lin S, Guo Q, Wen J, Li C, Lin J, Cui X, et al. Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas. J Exp Clin Cancer Res. 2014;33:26.
Hayase S, Sasaki Y, Matsubara T, Seo D, Miyakoshi M, Murata T, et al. Expression of stanniocalcin 1 in thyroid side population cells and thyroid cancer cells. Thyroid. 2015;25(4):425–36.
Saito Y, Onishi N, Takami H, Seishima R, Inoue H, Hirata Y, et al. Development of a functional thyroid model based on an organoid culture system. Biochem Biophys Res Commun. 2018;497(2):783–9.
Van Vliet G. Development of the thyroid gland: lessons from congenitally hypothyroid mice and men. Clin Genet. 2003;63(6):445–55.
Klonisch T, Hoang-Vu C, Hombach-Klonisch S. Thyroid stem cells and cancer. Thyroid. 2009;19(12):1303–15.
Davies TF, Ando T, Lin RY, Tomer Y, Latif R. Thyrotropin receptor-associated diseases: from adenomata to graves disease. J Clin Invest. 2005;115(8):1972–83.
Zheng X, Cui D, Xu S, Brabant G, Derwahl M. Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells. Int J Oncol. 2010;37(2):307–15.
Friedman S, Lu M, Schultz A, Thomas D, Lin RY. 'CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin. PLoS One. 2009;4(4):e5395.
Mirshahidi S, Simental A, Lee SC, De Andrade Filho PA, Peterson NR, Cao W, et al. Subpopulations of cancer stem cells found in papillary thyroid carcinoma. Exp Cell Res. 2018;362(2):515–24.
Grosse-Gehling P, Fargeas CA, Dittfeld C, Garbe Y, Alison MR, Corbeil D, et al. CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges. J Pathol. 2013;229(3):355–78.
Canettieri G, Franchi A, Sibilla R, Guzmán E, Centanni M. Functional characterisation of the CRE/TATA box unit of type 2 deiodinase gene promoter in a human choriocarcinoma cell line. J Mol Endocrinol. 2004;33(1):51–8.
Ambrosio R, De Stefano MA, Di Girolamo D, Salvatore D. Thyroid hormone signaling and deiodinase actions in muscle stem/progenitor cells. Mol Cell Endocrinol. 2017;459:79–83.
Visser TJ. Thyroid hormone transport across the placenta. Ann Endocrinol (Paris). 2016;77(6):680–3.
Casula S, Bianco AC. Thyroid hormone deiodinases and cancer. Front Endocrinol (Lausanne). 2012;3:74.
Shimamura M, Yamamoto K, Kurashige T, Nagayama Y. Intracellular redox status controls spherogenicity, an in vitro cancer stem cell marker, in thyroid cancer cell lines. Exp Cell Res. 2018;370(2):699–707.
Zhao W, Chen S, Hou X, Chen G, Zhao Y. CHK2 promotes Anoikis and is associated with the progression of papillary thyroid Cancer. Cell Physiol Biochem. 2018;45(4):1590–602.
Author information
Authors and Affiliations
Contributions
EA designed the idea, EA and KA drafted and revised the manuscript, KA designed the figure while EA drafted the table. Both authors approved the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Author disclosure statement
No competing financial interests exist.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Al-Suhaimi, E.A., Al-Khater, K. Functions of stem cells of thyroid glands in health and disease. Rev Endocr Metab Disord 20, 187–195 (2019). https://doi.org/10.1007/s11154-019-09496-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11154-019-09496-x